Researchers discover new gene that regulates body weight

January 4, 2012 in Genetics

Abraham Kovoor was studying a brain protein, called RGS9 2, that he had previously related to the involuntary, random and repetitive body movements that are side effects of drugs used to treat Parkinson's disease and schizophrenia.

While studying these , which are called dyskinesia, Kovoor, an assistant professor in the University of Rhode Island's College of Pharmacy, discovered that RGS9 2 also plays a role in regulating .

Results of his study were published in the November issue of , an interactive open-access, peer-reviewed scientific and medical research journal.

Kovoor and his collaborators found that humans with a that could reduce RGS9 2 levels had a significantly higher .

Similarly, when they examined a strain of mice in which the RGS9 2 gene was deleted, so that these mice do not make RGS9 2 protein, they found that these weighed more than the wild-type strain and the percentage of was much greater. Conversely, when RGS9-2 protein is over-expressed in rats, they found that the rats lost weight.

Because RGS9-2 is normally expressed in the brain's striatum, a section of the brain involved in both motor control and reward responses, Kovoor and his fellow researchers thought that the could be a result of an increased reward response triggered during eating.

"You would expect more eating from the mice without RGS9-2 (because they were the ones that gained weight), but that was not the case," Kovoor said. "Studies with humans, rats and mice implicate RGS9-2 as a factor in regulating body weight. But we had to look at another factor other than feeding behavior".

"Our research shows that the striatum, through RGS9-2, has a role in regulating body weight that is independent of the motivation, movement and reward responses," Kovoor said. "We have identified a new gene that likely regulates weight gain through metabolism."

Surprised by the discovery, Kovoor said he and his team have been studying RGS9-2 and its role in the movement side effects of drug therapy for Parkinson's disease and schizophrenia for almost a decade.

In fact, a company he established, Kovogen LLC, now based in Mystic, Conn., is developing methods for predicting which individuals are more likely to get these irreversible and debilitating side effects so that drug treatment can be optimized and tailored for individual patients.

"When you see Michael J. Fox continuously weaving and shaking, his movements are actually dyskinesia, a reaction to the medication used to treat his Parkinson's. Many people mistakenly assume that the shaking is a result of his Parkinson's disease, but the disease itself causes rigidity. Anti-psychotic drugs, which are used to treat , also cause similar involuntary movements that are irreversible.

"When we began looking at RGS9-2, nobody had an inkling as to why these drugs cause dyskinesias. We showed very early on that RGS9-2 modulates the function of the dopamine receptors, and dopamine receptors are the major targets of Parkinson's and anti-psychotic drugs," Kovoor said.

"We treated RGS9-2 knockout mice (those without the RGS9-2 gene) with anti-psychotic drugs or with L-DOPA, a drug used to treat Parkinson's disease, and the mice all rapidly developed dyskinetic movement disorders when being treated.

"RSG9-2 provided a springboard for investigating how drugs produce these disorders," Kovoor said.

In fact, prompted by Kovoor's discovery, one of his collaborators, Stephen Gold, and his colleagues at the University of Texas, were able to show that gene therapy with RGS9-2 could suppress drug-induced dyskinesias in monkeys.

"Separately, we were looking to see if we could predict the risk susceptibility for these (movement) disorders by searching for variations in the RGS9-2 gene in humans."

Kovoor and his fellow researchers at the University of California in San Francisco also monitored the body mass index of patients in their study. "We noticed that study subjects with a variation in the RGS9-2 gene, which could weaken expression of the gene, had a higher index."

Parallel experiments in mice and rats confirmed these findings implicating RGS9-2 in weight regulation.

Provided by University of Rhode Island (news : web)

4.8 /5 (4 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Xbw
Jan 04, 2012

Rank: not rated yet
My wife must be swimming with RGS9-2 because she eats 3 times more than me and is a twig. I'll take a lifetime supply please.
Rank 4.8 /5 (4 votes)
Relevant PhysicsForums posts

More news stories

Uncovered: Genetic cause of complex disease seen in Irish Traveller community

Two independent groups of researchers — one led by Adrian Clark, at Queen Mary University of London, United Kingdom; and the other led by Jean-Laurent Casanova, at The Rockefeller University, New York — have now ...

Genetics created 10 hours ago | popularity 5 / 5 (2) | comments 0

Unraveling why children with Down syndrome have increased leukemia risk

Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a ...

Genetics created 10 hours ago | popularity 5 / 5 (1) | comments 0

Exposure to micronutrients pre-pregnancy associated with gene modifications in offspring

The offspring of women who were given micronutrient supplements (minerals needed in small quantities, such as iron, iodine and vitamin A) before they became pregnant had gene modifications at birth as well as when they were ...

Genetics created 11 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

New book ponders ethical issues of genetic testing

A patient who tested positive for the gene that leads to Huntington’s disease wrestled with a host of questions. Should she have children with her husband, knowing that each baby has a 50-50 chance of inheriting the ...

Genetics created 15 hours ago | popularity 5 / 5 (1) | comments 0

Specially-bred mice help target an annual outbreak: the flu

As part of a national collaboration, Oregon Health & Science University researchers are studying specially bred mice that are more like humans than ever before when it comes to genetic variation. Through these mice, the researchers ...

Genetics created Feb 21, 2012 | popularity 5 / 5 (1) | comments 0


Mini molecules could help fight battle of aortic bulge

When aortic walls buckle, the body's main blood pipe forms an ever-growing bulge. To thwart a deadly rupture, a team of Stanford University School of Medicine researchers has found two tiny molecules that may be able to orchestrate ...

Research links circadian rhythms to sudden cardiac death

A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abn ...

Analysis of mTOR shows how the protein works, how new generation of drugs may defeat it

Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered ...

Phobia's effect on perception of feared object allows fear to persist

The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.

New melanoma drug Zelboraf nearly doubles survival in majority of patients

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.

Study: No significant rise in seizure risk from common kids' vaccine

(HealthDay) -- Children who receive a combination vaccine known as DTaP-IPV-Hib have no significant increased risk of febrile seizure, a convulsion triggered by a fever, during the week after vaccination, ...